Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-06-14
2005-06-14
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S552000
Reexamination Certificate
active
06906058
ABSTRACT:
The present invention relates to compounds of formula (I) wherein R1and R2are independently selected from C1-6alkyl; one of R4and R5is a group of formula (IA): R3, R6, R7, R8, R9, R10and R11and the other of R4and R5are as defined within, pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and there use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
REFERENCES:
patent: 19825804 (1999-12-01), None
patent: 0 864 582 (1998-09-01), None
patent: 93/16055 (1993-08-01), None
patent: 94/18183 (1994-08-01), None
patent: 94/18184 (1994-08-01), None
patent: 96/05188 (1996-02-01), None
patent: 96/08484 (1996-03-01), None
patent: 96/16051 (1996-05-01), None
patent: 97/33882 (1997-09-01), None
patent: 98/38182 (1998-09-01), None
patent: 98/40375 (1998-09-01), None
patent: 99/34278 (1999-07-01), None
patent: 99/35135 (1999-07-01), None
patent: 99/64409 (1999-12-01), None
patent: 99/64410 (1999-12-01), None
patent: 00/01687 (2000-01-01), None
patent: 00/38725 (2000-07-01), None
patent: 00/38726 (2000-07-01), None
patent: 00/38727 (2000-07-01), None
patent: 00/38728 (2000-07-01), None
patent: 00/38729 (2000-07-01), None
patent: 00/47568 (2000-08-01), None
patent: 00/61568 (2000-10-01), None
patent: 00/62810 (2000-10-01), None
patent: 01/60807 (2001-08-01), None
patent: 01/68096 (2001-09-01), None
patent: 01/68637 (2001-09-01), None
patent: 02/08211 (2002-01-01), None
patent: 02/32428 (2002-04-01), None
patent: 02/50051 (2002-06-01), None
patent: 03/020710 (2003-03-01), None
patent: 03/022286 (2003-03-01), None
patent: 03/022825 (2003-03-01), None
patent: 03/022830 (2003-03-01), None
Blomberg David
Dahlström Mickael
Starke Ingemar
AstraZeneca AB
Kifle Bruck
Morgan & Lewis & Bockius, LLP
LandOfFree
1,5-Benzothiazepines and their use as hypolipidaemics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,5-Benzothiazepines and their use as hypolipidaemics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,5-Benzothiazepines and their use as hypolipidaemics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3481375